Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

San Francisco

Gainesville

Atlanta

Chicago

Indianapolis

Lexington

Louisville

Baton Rouge

Baltimore

Boston

Rochester

Lincoln

Great Neck

New York

Chapel Hill

Charlotte

Cincinnati

Cleveland

Oklahoma City

Portland

Philadelphia

Pittsburgh

Charleston

Germantown

Kingsport

Nashville

Dallas

Galveston

Houston

Seattle

Milwaukee

Innsbruck

Oberpullendorf

Vienna

Bonheiden

Brussels

Genk

Ghent

Kortrijk

Leuven

Liège

Roeselare

Edmonton

Vancouver

London

Richmond

Toronto

Calgary

Aalborg

Aarhus

Copenhagen

Herlev

Amiens

Clichy

Grenoble

Lille

Montpellier, Cédex 5

Paris

Pessac

Rouen

Toulouse

Berlin

Hamburg

Hanover

Herne

Kiel

Leipzig

Minden

Munich

München

Bari

Bologna

Milan

Padua

Palermo

Roma

Torino

Amsterdam

Eindhoven

Enschede

Heerlen

Leiden

Terneuven

Zwolle

Oslo

Tromsø

Barcelona

Madrid

Oviedo

Santiago de Compostela

Seville

Valencia

Gothenburg

Malmo

Örebro

Stockholm

Basel

Bern

Lausanne

Bristol

Cambridge

Edinburgh

London

Nottingham

Oxford

Sheffield

Nice